Should the pH of the product exceed 8.5, endothelial damage may occur, according to the literature. Because Vitrex II may not meet the predefined specification for pH, AMO is voluntarily recalling the product.
A list of affected lot numbers is available in the news release.
Read the AMO release about the Vitrex II recall (pdf).
At the Becker’s 32nd Annual Meeting: The Business and Operations of ASCs, taking place October 29-31 in Chicago, ASC leaders, surgeons and healthcare executives will explore strategies to drive growth, enhance operational performance, navigate reimbursement challenges and prepare for the future of ambulatory surgery. Apply for complimentary registration now.
